Cannabix
Technologies Launches New Compact Breath
Logix Workplace
Series and Prepares for
Delivery to South Africa
Cannabix
is developing alcohol and marijuana breathalyzer devices to give
law enforcement and employers a tool to enhance public
safety
Vancouver, British Columbia, Canada
-- May 7, 2024 -- InvestorsHub NewsWire -- Cannabix Technologies
Inc. (CSE:
BLO) (OTC
PINK: BLOZF) (Frankfurt: 8CT) (the "Company or Cannabix")
developer of alcohol and marijuana breathalyzer screening devices
announces the launch of its new Breath Logix Workplace Series
-Alcohol
breath detection device. The
Workplace
Series is an autonomous
compact wall mounted unit that is designed for indoor facilities
and offices (Figure 1). The Breath Logix Workplace
Series is the newest device
within the Breath Logix series of autonomous alcohol screen
devices. Compared to the Breath Logix Industrial
Series, the
Workplace
Series provides a
smaller, lighter design that is suitable for a range of workplace
and commercial environments. The Company also reports that it has commenced
discussions with Run Rite Electronics Pty Ltd of Durban, South
Africa for the potential sales distribution of the Company's new
Breath Logix Workplace
Series. The Company expects to
deliver its device for evaluation, preliminary marketing and
business development purposes in May.
Justin Goldblatt, Managing Director
of Run Rite Electronics stated, "We really like the compact
size of the Breath Logix Workplace
Series for existing
and new customers in our market. A smaller, elegant wall mounted
alcohol breathalyzer with integration capabilities is of particular
interest to us. Based in South Africa, we have business
relationships across the continent."
Figure
1. New Breath Logix
Workplace
Series device (left), compared
to the Breath Logix Industrial Series
(right).
Breath Logix
Workplace
Series Features
The Breath Logix Workplace Series
has a sleek, compact
design with a host of features including patent pending
pre-calibrated cartridge technology which will allow site safety
administrators to easily maintain their devices, and eliminate the
need for costly calibration equipment and time-consuming site
visits from technicians for maintenance. This device can be used for
pre-access alcohol testing, random testing, start-of-shift testing,
pre-employment testing, return-to-work testing and post-incident
testing. The technology promotes
organizational safety and works to reduce accidents linked to
alcohol consumption.
The Breath Logix Alcohol device
automatically checks the sobriety of a user and can take a picture
to confirm and record identity while a breath sample is being
delivered. Upon detection of positive breath alcohol result, the
device will deliver a precise Blood Alcohol Content (BAC) level on
the screen, and send a real-time alert via text message, e-mail and
to a dedicated web portal. Furthermore, the system logs user BAC
for incident reporting and historical
investigations. The Breath Logix helps organizations
save money by deploying an autonomous alcohol screening device
which eliminates the need for dedicated alcohol screening
administrators using conventional handheld devices. There is no
assurance that evaluators of the Company's breathalyzer technology
will come to terms on distribution or enter into a sales agreement
with the Company.
About Cannabix Technologies
Inc.
Cannabix Technologies Inc. is a
developer of marijuana and alcohol breathalyzer technologies for
law enforcement, workplaces and laboratories. Cannabix is
developing delta-9 THC and alcohol screening devices. Delta-9 THC
is the psychoactive component of marijuana that causes impairment.
Breath testing for delta-9 THC would allow employers and law
enforcement to identify recent marijuana use.
Cannabix is the developer of Breath Logix Series of autonomous
breath alcohol detection devices for employers and a range of other
settings.
We seek Safe
Harbor.
On
behalf of the Board of Directors
"Rav Mlait"
CEO
Cannabix Technologies Inc.
For further information, contact the
Company at
info@cannabixtechnologies.com
The CSE has not
reviewed and does not accept responsibility for the adequacy or
accuracy of this release.
Cautionary Statement
Regarding Forward-Looking Statements
This press release
contains forward-looking information that involves various risks
and uncertainties regarding future events. Such forward-looking
information can include without limitation statements based on
current expectations involving a number of risks and uncertainties
and are not guarantees of future performance of the Company, such
as final development of a commercial or prototype product(s),
successful trial or pilot of company technologies, no assurance
that commercial sales of any kind actually materialize; no
assurance the Company will have sufficient funds to complete
product development. There are numerous risks and uncertainties
that could cause actual results and the Company's plans and
objectives to differ materially from those expressed in the
forward-looking information, including: (i) adverse market
conditions; (ii) risks regarding protection of proprietary
technology; (iii) the ability of the Company to complete
financings; (iv) the ability of the Company to develop and market
its future product; and (v) risks regarding government regulation,
managing and maintaining growth, the effect of adverse publicity,
litigation, competition and other factors which may be identified
from time to time in the Company's public announcements and
filings. There is no assurance that its development of breathalyzer
technology will provide any benefit to the Company, and no
assurance that any proposed new products will be built, will be
successful in beta testing or clinical trials. There is no
assurance that evaluators of the Company's breathalyzer technology
will agree or come to terms on distribution or enter into a sales
agreement, of any kind. There is no assurance that existing "patent
pending" technologies licensed by the Company will receive patent
status by regulatory authorities. The Company is not currently selling
commercial breathalyzers. Actual results and future events could
differ materially from those anticipated in such information. These
and all subsequent written and oral forward-looking information are
based on estimates and opinions of management on the dates they are
made and are expressly qualified in their entirety by this notice.
Except as required by law, the Company does not intend to update
these forward-looking statements.
501-3292 Production
Way, Burnaby, B.C., V5A 4R4
Phone: (604)
551-7831
Fax:
604-676-2767
info@cannabixtechnologies.com
cannabixtechnologies.com